Who is sponsoring NCT03563105?

NCT03563105 is sponsored by Modulated Imaging Inc..

What drugs are being tested in NCT03563105?

Interventions in NCT03563105: The Ox-Imager Mini (Desaturation).

What condition does NCT03563105 study?

NCT03563105 studies Circulatory; Change.

Is NCT03563105 still recruiting?

NCT03563105 is currently status unknown. Last updated 20 June 2018.

Last reviewed 2018-06-20 · How we verify

NCT03563105

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessment of Circulatory Compromise With Ox-Imager Using a Vascular Occlusion Test Protocol

Status unknown NA Last updated 20 June 2018

What this trial tests

NA trial testing The Ox-Imager Mini (Desaturation) in Circulatory; Change in 50 participants. Status unknown.

Timeline

30 May 2018

Primary endpoint
1 May 2019

1 May 2019

Quick facts

Lead sponsor	Modulated Imaging Inc.
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	50
Start date	30 May 2018
Primary completion	1 May 2019
Estimated completion	1 May 2019
Sites	1 location across United States

Drugs / interventions tested

The Ox-Imager Mini (Desaturation)

Conditions studied

Circulatory; Change — all drugs for Circulatory; Change →

Sponsor

Modulated Imaging Inc.

Who can join

18 and older, any sex, with Circulatory; Change. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to evaluate the performance of Modulated Imaging Inc.'s (MI) next generation Spatial Frequency Domain Imaging (SFDI) system to measure potential circulatory compromise.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Modulated Imaging Inc. trials

Trials by the same sponsor.

NCT03144050 — Optical Imaging For Assessment of Foot Perfusion · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03563105 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Modulated Imaging Inc.
Last refreshed: 20 June 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03563105.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing